Dr Sonali Gnanenthiran (MBBS [Hons I], PhD, FRACP, FCSANZ) is a cardiologist at The George Institute for Global Health and Concord Hospital, Australia. Her clinical and research interests include cardiovascular disease prevention and risk assessment. She completed a PhD with the University of Sydney. She was a recipient of the John Chalmers Fellowship at The George Institute, and a Heart Foundation post-doctoral fellowship. She has >50 publications and has been awarded >$18.5 million in research funding. She has been awarded the 2023 American Heart Association Karl Link Award for Thrombosis, 2022 American Heart Association Paul Dudley White International Scholar Award, 2021 Scientific Medal of the Thrombosis and Haemostasis Society of Australia and New Zealand, 2020 American Heart Association Paul Dudley White International Scholar Award, and 2018 Best Poster Presentation at the European Society of Cardiology scientific meeting.

A/Prof Shane Hamblin is Head of Endocrinology & Diabetes at Western Health, Melbourne and is an honorary Associate Professor at the University of Melbourne and Deakin University. He is a member of the Pharmaceutical Benefits Advisory Committee and is the current President of the Endocrine Society of Australia. His main research interest is in the pharmacoepidemiology of type 2 diabetes and he is a part-time PhD student in the School of Public Health and Preventive Medicine at Monash University.

Neale Cohen is currently the Director of Clinical Services at the Baker Heart and Diabetes Institute in Melbourne. He is an endocrinologist practicing at the Baker Institute in Melbourne. He is responsible for the management of one of Australia’s largest Melbourne based diabetes services, with additional services in Footscray and a Victorian Telehealth service. He is an Associate Professor at University of Queensland and Monash University. His clinical research interests and publications include diabetes technology, diabetes therapeutics and indigenous diabetes.